Arif Bilal

KalVista Pharmaceuticals, Inc. ยท Chief Operations Officer

Arif Bilal is listed in public filings as officer: Chief Operations Officer. This Arif Bilal insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include KalVista Pharmaceuticals, Inc. (KALV), and Sarepta Therapeutics, Inc. (SRPT). Investors use Arif Bilal's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
KalVista Pharmaceuticals, Inc.KALV--49k sharesGrant / ExerciseJan 16, 2026Disclosure amount unavailable49k shares----

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
KalVista Pharmaceuticals, Inc.KALV$1.1M100k sharesGrant / ExerciseOct 8, 2025$1.1M100k shares$11.49--
Sarepta Therapeutics, Inc.SRPT--6.3k sharesGrant / ExerciseAug 5, 2025Disclosure amount unavailable6.3k shares----
Sarepta Therapeutics, Inc.SRPT$1.7M16.6k sharesGrant / ExerciseMar 10, 2025$1.7M16.6k shares$99.69--
Sarepta Therapeutics, Inc.SRPT--32.5k sharesGrant / ExerciseMar 10, 2025Disclosure amount unavailable8.3k shares----
Sarepta Therapeutics, Inc.SRPT$2.4M24.2k sharesGrant / ExerciseMar 10, 2025$52.4K523 shares$100.13--
Sarepta Therapeutics, Inc.SRPT$2.6M24.7k sharesGrant / ExerciseMar 7, 2025$884.3K8.5k shares$103.70--
Sarepta Therapeutics, Inc.SRPT$3.5M33.3k sharesGrant / ExerciseMar 7, 2025$52.7K508 shares$103.70--
Sarepta Therapeutics, Inc.SRPT--17.5k sharesGrant / ExerciseMar 6, 2025Disclosure amount unavailable17.5k shares----
Sarepta Therapeutics, Inc.SRPT$1.7M16.5k sharesGrant / ExerciseMar 4, 2025$28.5K281 shares$101.34--
Sarepta Therapeutics, Inc.SRPT$1.7M16.3k sharesGrant / ExerciseMar 4, 2025$23.6K233 shares$101.34--
Sarepta Therapeutics, Inc.SRPT$1.7M16.8k sharesGrant / ExerciseMar 3, 2025$74.6K719 shares$103.77--
Sarepta Therapeutics, Inc.SRPT--17.5k sharesGrant / ExerciseFeb 11, 2025Disclosure amount unavailable3.5k shares----
Sarepta Therapeutics, Inc.SRPT$2.8M17.4k sharesSellJun 25, 2024$636.3K3.9k shares$163.23--
Sarepta Therapeutics, Inc.SRPT$3.8M23.5k sharesSellJun 24, 2024$905.7K5.6k shares$162.31--
Sarepta Therapeutics, Inc.SRPT$4.8M29.1k sharesGrant / ExerciseJun 24, 2024$387.2K2.4k shares$164.64--
Sarepta Therapeutics, Inc.SRPT$3.7M22.5k sharesSellJun 24, 2024$172.8K1.1k shares$163.83--
Sarepta Therapeutics, Inc.SRPT$3.6M21.5k sharesSellJun 24, 2024$116.3K700 shares$166.10--
Sarepta Therapeutics, Inc.SRPT$3.7M22.2k sharesSellJun 24, 2024$49.4K300 shares$164.61--
Sarepta Therapeutics, Inc.SRPT$3.6M21.3k sharesSellJun 24, 2024$37.4K224 shares$167.13--
Sarepta Therapeutics, Inc.SRPT--6.3k sharesGrant / ExerciseJun 21, 2024Disclosure amount unavailable6.3k shares----
Sarepta Therapeutics, Inc.SRPT--6.3k sharesGrant / ExerciseJun 21, 2024Disclosure amount unavailable6.3k shares----